Lawstreet Journal

Serum Institute of India files Rs. 100 crore Defamation Case After Volunteer Claims of Falling Sick Due to Vaccine Trial

Lawstreet Journal 1 Dec 2020 12:24am

Image courtesy: Lawstreet Journal Business Serum Institute of India files Rs. 100 crore Defamation Case After Volunteer Claims of Falling Sick Due to Vaccine Trial

The Serum Institute of India on Sunday (November 20, 2020) filed a Rs. 100 crore defamation suit against a Chennai-based volunteer who took part in their COVID-19 vaccine trial and alleged that it triggered an adverse reaction and suffer a neurological breakdown after taking a dose.

Serum Institute has partnered with drug manufacturer Astra Zeneca and the University of Oxford to produce the Covishield vaccine in the country. The vaccine is seen as a possible option for many developing countries because of its cheaper price and ability to be transported and stored at normal temperatures.

The volunteer aged 40 years sought Rs. 5 crores from Serum Institute citing side effects of virtual neurological breakdown and impairment of cognitive functions after taking the dose of the Covid shot. However, the Serum Institute denied the allegations and called them “malicious” and “misconceived”. 

He also sent a legal notice to ICMR, DCGI, AstraZeneca, and Oxford University to stop testing, manufacturing, and distributing vaccines. In the legal notice, he claims that he experienced headaches and then endured a seven-day stay in the intensive care unit (ICU). ​

We haven’t received any response from any of the parties to whom we have sent the notice. We will be left with no other option but to go ahead and file a writ petition and get ready for a legal battle,” advocate R. Rajaram, on behalf of the Volunteer said.

In a statement, a Serum Institute spokesperson said that while it sympathized with the volunteer's medical condition there was "absolutely no correlation with… Continue Reading...


Tagged: Corona Updates  
Disclaimer: SoOLEGAL in Media collaboration with Lawstreet Journal. SoOLEGAL take no responsbility for the content provided by Lawstreet Journal. For any discrepancies Contact Lawstreet Journal.
Did you find this write up useful? YES 0 NO 0
Featured Members view all

New Members view all

×

C2RMTo Know More

Something Awesome Is In The Work

0

DAYS

0

HOURS

0

MINUTES

0

SECONDS

Sign-up and we will notify you of our launch.
We’ll also give some discount for your effort :)

* We won’t use your email for spam, just to notify you of our launch.